Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% is contraindicated for use by patients having a known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

physicians total care, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% is contraindicated for use by patients having a known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sulfacetamide sodium topical suspension usp, 10% (lotion) is indicated in the topical treatment of acne vulgaris . sulfacetamide sodium topical suspension usp, 10% (lotion) is contraindicated for use by patients having known hypersensitivity to sulfonamides or any other component of this preparation (see warnings section).

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

allergan, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - blephamide ® ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular antibacterial drug in this product is active against the following common bacterial eye pathog

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

sandoz inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications and usage: sulfacetamide sodium ophthalmic solution usp, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. contraindications: sulfacetamide sodium ophthalmic solution is contraindicated in individuals who have a hypersensitivity to sulfonamides or to any ingredient of the preparation.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

trinity pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - indications: sulfacetamide sodium and sulfur cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sulfacetamide sodium and sulfur cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sulfacetamide sodium and sulfur cleanser is not to be used by patients with kidney disease. pediatric use - safety and effectiveness in children under the age of 12 have not been established.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

direct rx - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa. a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

padagis us llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms: escherichia coli, staphylococcus aureus, staphylococcus pneumonia, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species . topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeroginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bi-coastal pharma international llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 98 mg in 1 g - indications: sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is not to be used by patients with kidney disease.